References
Giglioli FR, Strigari L, Ragona R et al (2016) Lung stereotactic ablative body radiotherapy: a large scale multi-institutional planning comparison for interpreting results of multi-institutional studies. Phys Med 32(4):600–606
Moustakis C, Blanck O, Tazehmahalleh FE et al (2017) Planning benchmark study for SBRT of early stage NSCLC results of the DEGRO working group Stereotactic Radiotherapy. Strahlenther Onkol. https://doi.org/10.1007/s00066-017-1151-8
Guckenberger M, Andratschke N, Alheit H et al (2014) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 190(1):26–33
Guckenberger M, Klement RJ, Allgäuer M et al (2016) Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. Radiother Oncol 118(3):485–491
Katoh N, Soda I, Tamamura H et al (2017) Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system. Radiat Oncol 12(1):3. https://doi.org/10.1186/s13014-016-0742-3
Guckenberger M, Allgäuer M, Appold S et al (2013) Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis. J Thorac Oncol 8(8):1050–1058. https://doi.org/10.1097/JTO.0b013e318293dc45
Zhao L, Zhou S, Balter P et al (2016) Planning target volume D95 and mean dose should be considered for optimal local control for stereotactic ablative radiation therapy. Int J Radiat Oncol Biol Phys 95(4):1226–1235
Lacornerie T, Lisbona A, Mirabel X et al (2014) GTV-based prescription in SBRT for lung lesions using advanced dose calculation algorithms. Radiat Oncol 9(1):223. https://doi.org/10.1186/s13014-014-0223-5
Seuntjens J, Lartigau EF, Cora S et al (2014) ICRU Report 91. J ICRU 14(2):NP. https://doi.org/10.1093/jicru/ndx017
Guckenberger M, Andratschke N, Dieckmann K et al (2017) ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother Oncol 124(1):11–17. https://doi.org/10.1016/j.radonc.2017.05.012
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
C. Moustakis, O. Blanck, F. Ebrahimi, M. ka heng Chan, I. Ernst, T. Krieger, M.-N. Duma, M. Oechsner, U. Ganswindt, C. Heinz, H. Alheit, H. Blank, U. Nestle, R. Wiehle, C. Kornhuber, C. Ostheimer, C. Petersen, G. Pollul, W. Baus, G. Altenstein, E. Beckers, K. Jurianz, F. Sterzing, M. Kretschmer, H. Seegenschmiedt, T. Maass, S. Droege, U. Wolf, J. Schoeffler, U. Haverkamp, H. Eich and M. Guckenberger declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Moustakis, C., Blanck, O., Ebrahimi, F. et al. Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches. Strahlenther Onkol 193, 1068–1069 (2017). https://doi.org/10.1007/s00066-017-1216-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-017-1216-8